Assessment of the effect of chemotherapy on ovarian function in women with breast cancer.
Anderson
Richard A
RA
Cameron
David A
DA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy / Q000379:methods; D008599:Menstruation Disturbances / Q000209:etiology / Q000503:physiopathology; D008875:Middle Aged; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000503:physiopathology; D018570:Risk Assessment; D012720:Severity of Illness Index